SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 10-Q (Amendment No. 1)
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the Quarter Ended January 31, 1995 Commission file Number 0-10964
MAXWELL LABORATORIES, INC.
Delaware IRS ID# 95-2390133
8888 Balboa Avenue,
San Diego, California 92123
Telephone (619) 279-5100
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
YES [X] NO [ ]
As of February 28, 1995 Registrant had only one class of common
stock of which there were 2,674,973 shares outstanding.
<PAGE>
PART II - OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K
________________________________
(a) Exhibits
________
Exhibit 27 - Financial Data Schedule
(b) Reports on Form 8-K
___________________
No reports on Form 8-K were filed during the quarter ended January
31, 1995.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
MAXWELL LABORATORIES, INC.
April 26, 1995 Gary J. Davidson
Date Gary Davidson, Chief Financial Officer
and Authorized Officer
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Consolidated Condensed Balance Sheet and the Consolidated Condensed Statement
of Income as filed in Item 1 on Form 10-Q and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> JUL-31-1995
<PERIOD-END> JAN-31-1995
<CASH> 1,724
<SECURITIES> 0
<RECEIVABLES> 15,375
<ALLOWANCES> 0
<INVENTORY> 8,869
<CURRENT-ASSETS> 29,858
<PP&E> 55,935
<DEPRECIATION> 35,239
<TOTAL-ASSETS> 51,924
<CURRENT-LIABILITIES> 11,537
<BONDS> 2,341
<COMMON> 267
0
0
<OTHER-SE> 35,253
<TOTAL-LIABILITY-AND-EQUITY> 51,924
<SALES> 35,548
<TOTAL-REVENUES> 35,548
<CGS> 25,992
<TOTAL-COSTS> 25,992
<OTHER-EXPENSES> 2,290
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 889
<INCOME-TAX> 284
<INCOME-CONTINUING> 560
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 560
<EPS-PRIMARY> .21
<EPS-DILUTED> .21
</TABLE>
